Guggenheim Capital’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-55,646
Closed -$26K 2997
2016
Q2
$26K Buy
55,646
+2,345
+4% +$1.1K ﹤0.01% 2794
2016
Q1
$73K Buy
53,301
+16,447
+45% +$22.5K ﹤0.01% 2781
2015
Q4
$54K Buy
36,854
+1,266
+4% +$1.85K ﹤0.01% 2889
2015
Q3
$56K Sell
35,588
-774
-2% -$1.22K ﹤0.01% 2846
2015
Q2
$62K Buy
36,362
+1,837
+5% +$3.13K ﹤0.01% 2946
2015
Q1
$48K Buy
34,525
+2,600
+8% +$3.62K ﹤0.01% 2933
2014
Q4
$48K Buy
31,925
+8,299
+35% +$12.5K ﹤0.01% 2921
2014
Q3
$48K Sell
23,626
-33,994
-59% -$69.1K ﹤0.01% 2932
2014
Q2
$177K Sell
57,620
-1,805
-3% -$5.54K ﹤0.01% 2926
2014
Q1
$148K Buy
59,425
+11,393
+24% +$28.4K ﹤0.01% 2954
2013
Q4
$238K Buy
48,032
+2,128
+5% +$10.5K ﹤0.01% 2789
2013
Q3
$105K Buy
45,904
+11,084
+32% +$25.4K ﹤0.01% 2847
2013
Q2
$78K Buy
+34,820
New +$78K ﹤0.01% 2854

Other funds holding RXII